NCT04357418 (ICOS) is a clinical trial of it is a survey in Anxiety State, sponsored by Centre hospitalier de Ville-Evrard, France.

Who is sponsoring NCT04357418?

NCT04357418 is sponsored by Centre hospitalier de Ville-Evrard, France.

What drugs are being tested in NCT04357418?

Interventions in NCT04357418: it is a survey.

What condition does NCT04357418 study?

NCT04357418 studies Anxiety State, COVID-19, Isolation, Social, Health Personnel Attitude.

Is NCT04357418 still recruiting?

NCT04357418 is currently completed. Last updated 3 August 2020.

Last reviewed 2020-08-03 · How we verify

NCT04357418: ICOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives

Completed Last updated 3 August 2020

What this trial tests

trial testing it is a survey in Anxiety State in 187 participants. Completed in 30 June 2020.

Timeline

1 April 2020

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Centre hospitalier de Ville-Evrard, France
Status	Completed
Study type	OBSERVATIONAL
Enrollment	187
Start date	1 April 2020
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	1 location across France

Drugs / interventions tested

it is a survey

Conditions studied

Anxiety State — all drugs for Anxiety State →
COVID-19 — all drugs for COVID-19 →
Isolation, Social — all drugs for Isolation, Social →
Health Personnel Attitude — all drugs for Health Personnel Attitude →

Sponsor

Centre hospitalier de Ville-Evrard, France

Who can join

18 and older, any sex, with Anxiety State or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the investigators is to study the psychological impact of the COVID-19 lockdown on the members of the Ville Evrard Hospital staff and their close relatives, and to identify potential lockdown conditions that could increase anxiety, anger and depressive symptoms in this population.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

SARS-Cov-2 Damage on the Nervous System and Mental Health.
Boulkrane MS, Ilina V, Melchakov R, Arisov M, et al · · 2022 · cited 4× · PMID 34191699 · DOI 10.2174/1570159x19666210629151303
The Impact of Government Lockdowns on the Mental Health of the General Population: A Systematic Review and Meta-analysis.
Okazaki Y, Tsujimoto Y, Yamada K, Saka N, et al · · 2025 · PMID 40453305 · DOI 10.7759/cureus.83249

Verify or expand the search:

Other recruiting trials for Anxiety State

Currently open trials in the same condition.

NCT06358612 — Evaluation of an Anxiety Reduction Tool During Thyroid Biopsies · NA · recruiting
NCT06698081 — The Effect of Using Multimedia During the Informed Consent Process on the Anxiety of Parents of Orchiopexy Patients · NA · recruiting
NCT06440460 — Intergenerational Study of War-Affected Youth · active not recruiting
NCT05752708 — Perioperative Anxiety Risk Factors in Parents of Children Undergoing Thoracic Surgery · recruiting
NCT05433389 — App Delivered Brief Mindfulness Intervention for Surgical Patients · NA · active not recruiting

Other Centre hospitalier de Ville-Evrard, France trials

Trials by the same sponsor.

NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
NCT07354633 — Full Sail Ahead, Sailing in Psychosocial Rehabilitation. · NA · recruiting
NCT06867783 — EVALUATION FOR YOUNG CHILDREN WITH AUTISM SPECTRUM DISORDERS · NA · active not recruiting
NCT05784961 — Impact of tDCS on Cannabis Craving in Schizophrenia · NA · not yet recruiting
NCT06263933 — Effect of Experience Sharing and Mutual Assistance on Insight and Recovery During the First Psychotic Episode · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04357418 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de Ville-Evrard, France
Last refreshed: 3 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04357418.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing